Publisher： Adis International
ISSN： 0114-9954
Source： Reactions Weekly, Vol.1, Iss.1285, 2010-01, pp. : 1-1
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Bevacizumab: increased risk of venous thromboembolism
Reactions Weekly, Vol. 1, Iss. 1230, 2008-01 ,pp. :
Access to resources
Recommend
Bevacizumab: increased risk of venous thromboembolism
Inpharma, Vol. 1, Iss. 1666, 2008-01 ,pp. :
Increased risk of death and thromboembolism with ESAs
Reactions Weekly, Vol. 1, Iss. 1192, 2008-01 ,pp. :
Oral, not transdermal, estrogens raise thromboembolism risk
Reactions Weekly, Vol. 1, Iss. 1291, 2010-01 ,pp. :
Oral HRT doubles venous thromboembolism risk
Inpharma, Vol. 1, Iss. 1641, 2008-01 ,pp. :